新疆再建一个大庆

国际油价持续高企，为减少对进口石油的依赖，国内资源的开发越来越迫切。6月2日结束的新疆石油石化发展战略与规划论证会提出，新疆要建重要的石油、天然气生产基地和石油天然气化工基地。到2010年，新疆油气产量将超过5000万吨，相当于再造一个大庆。     

海南计划建成重要油气化工基地

依托南中国海丰富的石油天然气资源和不断涌入的企业投资，海南正在实施宏伟的产业发展计划——从2004年开始，经过5年左右时间的大规模开发建设，使海南岛成为中国重要的石油天然气化工生产基地。     

第二届国际非常规油气资源大会

随着中国经济的快速发展，国内常规油气的开发生产已不能满足经济发展的需要，必须寻求新的出路。进入21世纪，全球经济进入新的发展周期，世界范围内油气产没和油气生产却相对不足，非常规石油、天然气资源开始受到更多的关注。     

中亚国家的能源开发与政策

特殊的地质构造使中亚拥有丰富的资源,而且大部分尚未被开发,特别是里海的石油和天然气是全球最具能源开发前景的地区之一。能源生产是中亚各国经济的重点领域,是这些     

俄罗斯的北极战略及其影响分析

一 北极对俄罗斯的重要战略地位 （一）开发北极资源是俄罗斯能源安全利益的保证。北极地区蕴藏着丰富的石油、天然气、矿物和渔业资源。据初步估算,该地区潜在的石油和天然气资源占世界尚未开发的油气资源的25％,北极地区的原油储量大概为2500亿桶,相当于目前被确认的世界原油储量的1／4;     

经济纵横

国家将确定以下16个重点建设地区。1.辽宁中南地区,发展钢铁工业和重型机电设备制造业。2.京津唐地区,加强机械电子工业发展。3.山东半岛,重点开发石油和海洋资源。4.长江三角洲地区,加快机械电子工业、石油化工、汽车的发展。5.闽南三     

中国天然气发展战略探讨

本文由环境问题引出能源的应用，通过石油、煤及天然气三种能源的比较。总结出天然气作为清洁能源的环境优势。天然气资源的开发和利用在近几年内得到了长足的发展，其资源优势明显，储量大，勘探程度低，未来勘探及消费潜力均很大。然而，随着“西气东输”的进程．天然气的发展已面临越来越多亟待解决的问题，如管道问题和天然气价格问题等。要解决这些问题就需要建立和完善目前我国的天然气法规，制定出有效合理的总体规划和战略才能更好地使天然气在新世纪成为主要的替代能源。     

新疆石油天然气产业竞争力研究——基于波特“钻石模型”的分析

本文在分析新疆石油天然气产业发展现状的基础上．运用波特的“钻石模型”理论从生产要素、需求状况、相关与支持性产业、产业战略组织与竞争状态四个方面对新疆石油天然气产业的竞争优劣势进行分析，并结合新疆的实际情况提出了提升新疆石油天然气产业竞争力的对策建议：加大勘探开发力度．增加后备储量：加强人力资源开发利用，吸引人才；增强技术创新能力，延伸产业链；带动相关产业的发展，促进新疆经济协调发展。     

运用价格杠杆促进水电资源开发

青海省是一个资源大省，资源丰富且门类齐全。水能资源得天独厚；石油、天然气资源前景广阔；盐湖及有色、非金属矿资源储量多、品种多、品位好。这些资源优势转化为经济优势，使资源变为财源，是全省人民要做的大文章。而水电资源的开发利用，是我省资源开发中的“重头戏...     

关于国内油气资源勘探开发实施“走出去”战略的随想

我国石油天然气勘探开发实施对外合作20多年来,成绩斐然,但困难和阻力也越来越大。我们有必要清醒认识当前世界油气资源勘探开发市场发展的主要趋势,方能在国际市场竞争中立于不败之地。     

石化企业应该大力发展第三方物流

通过对石化企业物流发展现状及问题的分析,提出发展第三方物流的方法策略,加强石化企业的管理,降低成本提高利润。     

The (Failed) Development of a Biotechnology Cluster: The Case of Lombardy

This paper discusses the development of the biotechnology industry in an Italian region, Lombardy. It asks why significant innovative activities in biotechnology did not emerge in what might have been considered at the outset a promising area for the growth of this industry and why in very recent years some timid symptoms of dynamism seem to be appearing. After an overview of the patterns of the development of biotechnology in Italy, the specific case of Lombardy, is described. Then, the paper discusses what kind of factors might explain the lagging behind of the Italian (and more generally, European) biotechnology industry vis-à-vis the United States.     

现代生物制药行业现状与发展前景

本文详细论述了现代生物技术在制药行业的应用与发展状况，指出生物制药业是目前生物技术发展最活跃，进展最快的产业之一，21世纪是生物制药行业飞速发展的时代。     

New Biotechnology Firms in Germany: Heidelberg and the BioRegion Rhine-Neckar Triangle

In Germany, in the second half of the nineties, a dynamic development of commercial biotechnology took place, undertaken by a considerable number of new firms. The following article deals with the foundation of biotechnological firms in the BioRegion Rhine-Neckar Triangle (with the center in Heidelberg). For a long time, the development of biotechnology in Germany and in the Rhine-Neckar Triangle was hindered by institutional barriers. The main reasons were the narrowing of company strategies of big chemical and pharmaceutical firms, the low impulses to found biotechnology companies out of academic research, the institutional surroundings not aligned to the needs of biotechnology (e.g. no venture capital market) and finally government restraints concerning the specific and particularly regional concentrated support of biotechnology. These particularities are also reflected by the structure of the population of young companies in the Rhine-Neckar Triangle. The main emphasis of biotechnology firms is placed on technological services (research on demand) and platform technologies, different sub-areas of therapeutics research (pharmaceutical basic materials, finding active substances), on the production for the diagnostics industry and on bioinformatics. These companies do not co-operate much, national and international relations predominate. Only a few scientists of regional research institutions want to found a biotechnology firm, although the region seems to attract a certain number of company founders from other regions.     

生物技术在资源与环境保护领域中的应用

本文从资源与环境保护的角度出发,重点论述了生物技术在这一领域的应用现状与发展前景,指出现代生物技术将会在21世纪的资源与环境保护领域中发挥重要作用。     

The Role of Innovation Policies in the Brazilian Health Biotechnology Regime

ABSTRACT

The Brazilian biotechnology health innovation regime can be understood as a phenomenon that results from the co-evolution of scientific, economic, and political factors. In order to analyze this co-evolution process, this article presents empirical evidence regarding the relationship between the public policy rationale devoted to promoting innovation activities and the development of health biotechnology in Brazil. Focusing on the 2002–2010 period, this article analyzes the different roles played by public policy on the development of Brazilian health biotechnology. The article is based on the analysis of two main dimensions: the national research capabilities and the dedicated biotechnology firms in Brazil. In this regard, the main conclusion is that public policies had a significant impact on both dimensions. However, the impact has been erratic and reflects strategic public policy weaknesses.     

极端微生物的应用进展

在过去的几十年里,众多极端微生物被拿到实验室进行培养,它们为生物技术研究提供了一个巨大的开发空间.近年来,随着生物技术研究逐渐成为21世纪研究的热点,新颖的培养方法、环境基因组学和完整基因组序列为开发极端微生物提供了新的手段,同时也为生物技术的工业化应用奠定了基础.     

生物技术创新对世界农产品贸易的影响及我国的对策研究

本文分析了世界各主要国家在生物技术管理方面的政策差异及其原因,分析了生物技术创新对世界农产品贸易的各种潜在和现实的影响,并对未来转基因农产品贸易的形势进行了初步的预测和判断。在此基础上,从短期和长期两个方面提出了今后我国生物技术发展和转基因农产品贸易的政策建议。     

现代发酵工程技术在食品开发中的应用

发酵工程在生物技术中占有重要地位,只有通过发酵工程,才能使基因工程或者细胞工程获得的特殊性状的细菌实现工业化生产,最终获得生物技术的生产效益和经济价值,即发酵工程是生物工程产业化的基础。发酵技术虽然古老,但是由于现代物技术研究成果的转化,为其注入新的内容,使传统的发酵工艺焕发新的生命力,使微生物发酵制品的品种不断增加。基于此,简要综述现代发酵工程技术在食品领域的应用及进展。     

The Ethics and Economics of Patenting the Human Genome

This paper attempts to better define the areas of conflict and agreement between value ethics and the theoretical ethics of the market processes at work in the biotechnology industry. Despite the apparent lack of ethics in an oligopolistically competitive pharmaceuticals industry, the paper concludes that the current stage of development of the medical biotechnology subindustry offers unparalleled opportunities for ethical systems to influence the market-based development of biotechnology. Ethical conversations between doctors and biologists with ethicists can help the market absorb more of the reflective wisdom that ethics brings when discussing such issue areas as justice, patents of the human genome, and modifications of the human genome. If conversations between ethicists and biotechnological managers and doctors are successful the metaphors of market-based financing may be refined and the knowledge base of the good increased.